Choosing the right cell line for breast cancer research DL Holliday, V Speirs Breast cancer research 13, 1-7, 2011 | 1949 | 2011 |
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex … M Dowsett, C Allred, J Knox, E Quinn, J Salter, C Wale, J Cuzick, ... Journal of clinical oncology 26 (7), 1059-1065, 2008 | 557 | 2008 |
Breast cancer cell lines: friend or foe? SE Burdall, AM Hanby, MRJ Lansdown, V Speirs Breast cancer research 5, 1-7, 2003 | 531 | 2003 |
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ... Breast Cancer Research 15, 1-37, 2013 | 523 | 2013 |
Pan-cancer image-based detection of clinically actionable genetic alterations JN Kather, LR Heij, HI Grabsch, C Loeffler, A Echle, HS Muti, J Krause, ... Nature cancer 1 (8), 789-799, 2020 | 505 | 2020 |
Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation AS Whale, JF Huggett, S Cowen, V Speirs, J Shaw, S Ellison, CA Foy, ... Nucleic acids research 40 (11), e82-e82, 2012 | 469 | 2012 |
Coexpression of estrogen receptor α and β: poor prognostic factors in human breast cancer? V Speirs, AT Parkes, MJ Kerin, DS Walton, PJ Carleton, JN Fox, SL Atkin Cancer research 59 (3), 525-528, 1999 | 380 | 1999 |
Increased expression of estrogen receptor β mRNA in tamoxifen-resistant breast cancer patients V Speirs, C Malone, DS Walton, MJ Kerin, SL Atkin Cancer research 59 (21), 5421-5424, 1999 | 362 | 1999 |
Phyto-oestrogens and breast cancer chemoprevention JL Limer, V Speirs Breast Cancer Research 6, 1-9, 2004 | 323 | 2004 |
Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model GP Skliris, K Munot, SM Bell, PJ Carder, S Lane, K Horgan, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003 | 277 | 2003 |
Nuclear and cytoplasmic expression of ERβ1, ERβ2, and ERβ5 identifies distinct prognostic outcome for breast cancer patients AM Shaaban, AR Green, S Karthik, Y Alizadeh, TA Hughes, L Harkins, ... Clinical Cancer Research 14 (16), 5228-5235, 2008 | 271 | 2008 |
In vivo models in breast cancer research: progress, challenges and future directions I Holen, V Speirs, B Morrissey, K Blyth Disease models & mechanisms 10 (4), 359-371, 2017 | 227 | 2017 |
Distinct expression patterns of ERα and ERβ in normal human mammary gland V Speirs, GP Skliris, SE Burdall, PJ Carder Journal of clinical pathology 55 (5), 371-374, 2002 | 224 | 2002 |
The rising incidence of male breast cancer V Speirs, AM Shaaban Breast cancer research and treatment 115, 429-430, 2009 | 217 | 2009 |
Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness A Avgustinova, M Iravani, D Robertson, A Fearns, Q Gao, P Klingbeil, ... Nature communications 7 (1), 10305, 2016 | 200 | 2016 |
Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer R Roylance, D Endesfelder, P Gorman, RA Burrell, J Sander, I Tomlinson, ... Cancer epidemiology, biomarkers & prevention 20 (10), 2183-2194, 2011 | 198 | 2011 |
Oestrogen receptor β: what it means for patients with breast cancer V Speirs, PJ Carder, S Lane, D Dodwell, MRJ Lansdown, AM Hanby The lancet oncology 5 (3), 174-181, 2004 | 184 | 2004 |
Loss of expression of oestrogen receptor β in colon cancer and its association with Dukes' staging N Jassam, SM Bell, V Speirs, P Quirke Oncology reports 14 (1), 17-21, 2005 | 181 | 2005 |
Male breast carcinoma: increased awareness needed J White, O Kearins, D Dodwell, K Horgan, AM Hanby, V Speirs Breast Cancer Research 13, 1-7, 2011 | 178 | 2011 |
Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin‐8 as a potential regulatory factor in breast tumours AR Green, VL Green, MC White, V Speirs International Journal of Cancer 72 (6), 937-941, 1997 | 178 | 1997 |